	Beneficio Bruto En Ventas		Fecha
Alaunos Therapeutics	USD -1.13M	1.11M	2024-09
Amgen	USD 6.48B	307M	2025-09
AstraZeneca	USD 12.39B	5M	2025-12
Baxter International	USD 577M	373M	2025-12
Biogen	USD 1.65B	34.6M	2025-12
Bioline Rx	USD 343K	111K	2025-09
Bristol-Myers Squibb	USD 8.79B	110M	2025-09
Celltrion	KRW 626.11B	81.75B	2025-09
Corcept Therapeutics	USD 199.58M	3.46M	2025-12
Cspc Pharmaceutical	CNY 4.34B	333.68M	2025-09
Curis	USD -7.72M	140K	2024-06
Deva Holding AS	TRY 1.32B	235.77M	2023-09
Dianthus Therapeutics	USD 396K	203K	2025-09
Divis Laboratories Ltd	INR 16.59B	2.05B	2025-12
Gilead Sciences	USD 6.31B	106M	2025-12
GlaxoSmithKline	GBP 6.18B	106M	2025-12
Incyte	USD 1.39B	118.68M	2025-12
Intrexon	USD -297K	167K	2024-06
Ionis Pharmaceuticals	USD 195M	40M	2025-12
J&J	USD 16.6B	118M	2025-12
Kangmei Pharma	CNY 270.29M	20.26M	2025-09
Karyopharm Therapeutics	USD -30.78M	1.29M	2024-12
Knight Therapeutics	CAD 44.83M	9.96M	2025-06
Laboratorios Farma	EUR 105.28M	177.08M	2025-06
Medical Developments International	AUD 7.35M	7.37M	2025-06
Merck	USD 13.42B	431M	2025-09
Neuren Pharmaceuticals	AUD 6.69M	6.37M	2025-06
Novartis	USD 10.82B	695M	2025-09
Organigram Holdings	CAD 31.84M	23.88M	2025-09
Pfizer	USD 3.54B	7.61B	2025-09
Pharma Mar	EUR 33.36M	20.25M	2025-09
PTC Therapeutics	USD 148.38M	39.31M	2025-12
Qiagen NV	USD 325.27M	19.53M	2025-12
Regeneron Pharmaceuticals	USD 3.3B	67M	2025-12
Roche Holding	CHF 22.09B	10.04B	2025-12
Sangamo BioSciences	-2.39M	1.09M	2024-06
Sartorius	EUR 393.2M	23M	2025-09
Sino Biopharmaceutical	CNY 10.5B	2.53B	2024-12
TG Therapeutics	USD 154.43M	20.81M	2025-12
Tilray	USD 67.63M	15.62M	2025-03
Verastem	USD 545K	543K	2021-12
Zz Pientze Pharmaceu	CNY 296.13M	1.1B	2025-06

Alaunos Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.